Severe Ulcerative Esophagitis Induced by Crizotinib Therapy

Crizotinib is an oral tyrosine-kinase inhibitor that inhibits anaplastic lymphoma kinase (ALK) in gene-rearranged non-small cell lung cancer (NSCLC). In 2011, the Food and Drug Administration approved crizotinib for treatment of locally advanced or metastatic ALK-positive NSCLC. The crizotinib adver...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACG Case Rep J
Hauptverfasser: Jalil, Ala' A Abdel, Craig, Jamie, Bajaj, Rajesh, Spurling, Timothy
Format: Artigo
Sprache:Inglês
Veröffentlicht: American College of Gastroenterology 2014
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4435292/
https://ncbi.nlm.nih.gov/pubmed/26157832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.2014.8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge